Risks and management of side effects of targeted therapies

被引：0
|
作者：
Gutzmer, R. [1 ]
Strumberg, D. [2 ]
机构：
[1] Hannover Med Sch, Hauttumorzentrum Hannover HTZH, Klin Dermatol Allergol & Venerol, Hannover, Germany
[2] Klin Ruhr Univ Bochum, Marienhosp Herne, Med Klin 3, Herne, Germany
来源：
ONKOLOGE | 2013年 / 19卷 / 10期
关键词：
Targeted therapies; Immunotherapy; Side effects; Molecular signalling pathways; Multikinase inhibitors; TYROSINE KINASE INHIBITORS; INDUCED DIARRHEA; CARDIOTOXICITY; MECHANISMS; HYPERTENSION;
D O I：
10.1007/s00761-013-2500-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Targeted therapies are increasingly being used in the medicinal therapy of tumors. The targeted manipulation of molecular signalling pathways or immune reactions can result in adverse effects which are in part novel and require special attention. Research and analysis of the literature. This article reviews the side effects of multikinase inhibitors, MAP kinase inhibitors (in particular EGFR, KIT and BRAF inhibitors) and CTLA-4 inhibitors and discusses the management. The knowledge of these side effects must be thoroughly inccorporated in the clinical examination and the treating physician should have a comprehensive knowledge of them.
引用
收藏
页码：863 / 869
页数：7
相关论文
共 50 条
  • [31] Kutane Nebenwirkungen zielgerichteter TherapienCutaneous side effects of targeted therapies
    H. F. Merk
    C. C. Zouboulis
    Der Hautarzt, 2018, 69 (4): : 266 - 267
  • [32] Targeted Therapies to Reduce Side Effects in Modern Drug Development
    Lin F.
    Genetic Engineering and Biotechnology News, 2021, 41 (12): : 24 - 26+28
  • [33] Skin changes as a result of targeted therapies in oncology patients. Cutaneous side effects of targeted therapies in oncology patients
    Kaehler, K. C.
    Hauschild, A.
    HAUTARZT, 2009, 60 (05): : 433 - 439
  • [34] Nanoparticle Therapies: Targeted Treatment for Bladder Cancer With Reduced Side Effects
    Sun, Jingguo
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2025, 20 : 989 - 990
  • [35] Side-effects associated with targeted therapies in renal cell carcinoma
    Soulieres, Denis
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) : 254 - 257
  • [36] Review: Side effects of approved molecular targeted therapies in solid cancers
    Widakowich, Christian
    De Castro, Gilberto, Jr.
    De Azambuja, Evandro
    Dinh, Phuong
    Awada, Ahmad
    ONCOLOGIST, 2007, 12 (12): : 1443 - 1455
  • [37] Side Effects of Bone-Targeted Therapies in Advanced Breast Cancer
    Domschke, Christoph
    Schuetz, Florian
    BREAST CARE, 2014, 9 (05) : 332 - 336
  • [38] Radiation therapy and targeted therapies: Risks and opportunities
    Nicolas, E.
    Lucia, F.
    CANCER RADIOTHERAPIE, 2022, 26 (6-7): : 973 - 978
  • [39] Managing side-effects of targeted therapies in renal cancer: surgical complications
    Chevreau, Christine
    Mejean, Arnaud
    Pocard, Marc
    BULLETIN DU CANCER, 2011, 98 : S61 - S67
  • [40] Side-effects of targeted therapies in the treatment of advanced renal cell carcinoma
    Kirchner, H.
    Merseburger, A. S.
    ONKOLOGE, 2011, 17 (02): : 155 - 162
12345